MENS: Jyong Biotech Company Aggregate Debts

Jyong Biotech Ltd focuses on creating botanical products for urology. Developing plant-based supplements for the global market helps diversify the portfolio and mitigate regional risks. The company's debt history on the GURU.Markets chart confirms the financial dynamics, where 0.00 reflects the latest metric value. However, reliance on government contracts and strict pricing control in China limit the business's margins.

MENS: Jyong Biotech Ltd Company Debts 06/18/2025 - 10/30/2026

Jyong Biotech (MENS) - metric breakdowns and financial figures

- share price and consensus valuation forecast:

Price Performance Chart Jyong Bio|MENS - Analyst Consensus Forecast

- market capitalization information:

Market Capitalization Jyong Biotech Corp|MENS - Total Company Value

- balance sheet equity data:

Accounting Value of a Share Jyong Biotech|MENS - Company Book Value|Market Cap to Net Assets Ratio jyongbio.com|MENS - Company Total Assets

- issuer credit burden and liquidity indicators:

- earnings and valuation multiples information:

MENS - Net Profit

Fundamental company analysis:MENS - Jyong Bio

Signature product of Jyong Biotech Limited

The development of plant-based pharmaceuticals and the diversification of sales markets for Jyong Biotech Ltd. (MENS) require precise capital management to scale expansion. Analyzing the overall debt burden, the investor assesses the balance between revenue stimulation and default risks, determining the company's ability to withstand a drop in demand without losing financial stability based on the dynamics of its liabilities.

Who Jyong Biotech Ltd competes with

HLN (Haleon Corp) - Aggregate Debt Obligations|Company Aggregate Debts KVUE (Kenvue Inc.)|Company Aggregate Debts veronapharma.com VRNA|LGND - Company Debts|Aggregate Debt Obligations AMRX (Amneal Pharmaceuticals, Inc.)|Perrigo Company (PRGO) - Company Debts|Company Total Debt Alvotech Biopharmaceuticals|LQDA (Liquidia Corporation) - Company Aggregate Debts|Company Aggregate Debts glpg.com|Company Total Debt ANIP (ANI Pharmaceuticals, Inc.)|MNKD (MannKind Corp) - Aggregate Debt Obligations|Company Debts Amphastar AMPH|Pacira Corp (PCRX) - Company Cumulative Debt|SPRY: Company Total Debt|theravance.com - Company Cumulative Indebtedness|AQST: Company Aggregate Debts|scPharmaceuticals - Aggregate Debt Obligations|TECX (Tectonic Therapeutic Inc.) - Company Aggregate Debts|Company Cumulative Debt Tonix Pharmaceuticals Holding TNXP|Company Debts China SXT Pharmaceuticals (SXTC)|EPRX (eupraxiapharma.com) - Aggregate Debt Obligations|Company Debts BioHarvest Sciences Inc. BHST|Company Cumulative Indebtedness EXOZ (Invizyne Technologies)|ORMP: Company Total Debt|Company Cumulative Debt Entera Bio Ltd.|MindWalk Holdings (HYFT) - Company Debts|Company Cumulative Debt abvcpharma.com (ABVC)|Company Debts Cumberland Pharmaceuticals Inc.|Company Aggregate Debt QNTM (Quantum BioPharma Ltd.)|Company Aggregate Debts FGEN|Telomir Pharmaceuticals Corp (TELO) - Company Total Indebtedness|Rani Therapeutics Holdings, Inc. - Company Total Debt|Aggregate Debt Obligations SNYR|Rallybio Corp. - Company Aggregate Debts|LEXX: Company Debts|PULM: Company Aggregate Debts|PTHL - Company Total Debt Obligations|Company Debts Aptorum Group Ltd|Company Cumulative Debt lyratherapeutics.com LYRA|Company Total Debt IBO (Impact BioMedical)|Company Cumulative Indebtedness TNFA|Company Aggregate Debts YCBD (cbdMD)|PainReform Corp (PRFX) - Company Cumulative Debt|Auris Medical - Company Aggregate Debts|lipella.com (LIPO) - Company Total Debt|OPTN: Company Aggregate Debts|Pieris Pharmaceuticals Inc - Aggregate Debt Obligations|Company Total Debt PROC|PTPI: Aggregate Debt Obligations|Company Debts Qilian International (QLI)|Company Debts SLRN (acelyrin.com)|TFF Pharmaceuticals, Inc. - Company Total Debt